A Generalized Response Surface Model with Varying Relative Potency for Assessing Drug Interaction
From MaRDI portal
Publication:5295352
DOI10.1111/J.1541-0420.2006.00579.XzbMATH Open1116.62122OpenAlexW2115023325WikidataQ40199191 ScholiaQ40199191MaRDI QIDQ5295352FDOQ5295352
Authors:
Publication date: 27 July 2007
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1111/j.1541-0420.2006.00579.x
Recommendations
- A Semiparametric Response Surface Model for Assessing Drug Interaction
- An extension of the model free test to test synergy in multiple drug combinations
- Nonlinear response surface in the study of interaction analysis of three combination drugs
- Optimal experimental designs for estimating the drug combination index in toxicology
- The additive damage model: a mathematical model for cellular responses to drug combinations
Applications of statistics to biology and medical sciences; meta analysis (62P10) Response surface designs (62K20)
Cites Work
Cited In (11)
- A mapping-based universal kriging model for order-of-addition experiments in drug combination studies
- Compromise design for combination experiment of two drugs
- An extension of the model free test to test synergy in multiple drug combinations
- Behaviour of the monotone single index model under repeated measurements
- Nonlinear response surface in the study of interaction analysis of three combination drugs
- A Semiparametric Response Surface Model for Assessing Drug Interaction
- A method for Bayesian monotonic multiple regression
- A model for the interaction of two chemicals
- Design and modeling for drug combination experiments with order effects
- A global model to define the behavior of partial agonists (bell-shaped dose-response inducers) in pharmacological evaluation of activity in the presence of the full agonist
- On dose-response modeling for evaluation of drugs combinations
Uses Software
This page was built for publication: A Generalized Response Surface Model with Varying Relative Potency for Assessing Drug Interaction
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5295352)